# Hbox Therapies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hbox-therapies

- Industry: Medical Devices & Equipment
- Headquarters: Aachen, Germany
- Website: www.hbox-therapies.com
- Total disclosed funding: $2.5M
- Latest round: Seed (Jan 22, 2023)
- Investors on record: 3

## About

Based in Germany, and founded in 2021 by co-founders Dr. Peter Schlanstein, Niklas Steuer, and Dr. Matthias Menne, HBOX Therapies GmbH operates as a medtech company engaged in developing a technology that facilitates lung-protective treatment of respiratory patients. In February 2023, Hbox Therapies raised EUR 3.3 million in seed funding led by TechVision Fonds, with participation from High-Tech Gründerfonds and an individual investor. 


HBOX Therapies GmbH develops a patented platform technology HBOX (Hyperbaric Blood Oxygenation) for miniaturized respiratory assistance in patients suffering from lung failure.

The company plans to use the seed funding to advance clinical testing.

## Funding rounds

- Seed, Jan 22, 2023, $2.5M — High-Tech Gruenderfonds, PB Beteiligung - und Vermoegensverwaltung, TechVision Fonds

## Investors

- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Seed
- PB Beteiligung - und Vermoegensverwaltung — Seed
- TechVision Fonds (https://capitalatlas.ai/funds/techvision-fonds) — Seed